CIK 0001528287
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 223550230
- Phone
- +1 650-237-2700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-18 | LACOB JOSEPH Director | Option exercise · Stock Option (Rt to Buy) | −192 | 0 | ||
| 2022-10-07 | Morrell Martha Chief Medical Officer | Option exercise | +192 | $0.03 | $5 | 56,780 |
| 2022-10-07 | Morrell Martha Chief Medical Officer | Option exercise | +384 | $0.03 | $10 | 57,164 |
| 2022-10-07 | Morrell Martha Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −192 | 0 | ||
| 2022-10-07 | Morrell Martha Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −384 | 0 | ||
| 2022-07-22 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −231 | $5.55 | $1K | 85,605 |
| 2022-07-22 | Kuhn Rebecca Chief Financial Officer | Shares withheld for taxes | −179 | $5.55 | $993 | 151,307 |
| 2022-06-13 | Andrade Lisa Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-13 | Fischer Frank M Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-13 | Garfield Greg Shaw Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-13 | Kumar Rakhi Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-13 | LACOB JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-13 | Ryan Renee Director | Grant or award · Stock Option (Right to Buy) | +18,253 | 18,253 | ||
| 2022-06-08 | Ridley Irina General Counsel and Secretary | Sale | −2,500 | $5.78 | $14K | 61,139 |
| 2022-04-22 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −926 | $8.32 | $8K | 85,836 |
| 2022-04-22 | Kuhn Rebecca Chief Financial Officer | Shares withheld for taxes | −718 | $8.32 | $6K | 151,486 |
| 2022-03-08 | Favet Michael Chief Executive Officer | Grant or award | +155,080 | 182,080 | ||
| 2022-03-08 | Favet Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +310,160 | 310,160 | ||
| 2022-03-03 | Ridley Irina General Counsel and Secretary | Grant or award | +56,987 | 63,639 | ||
| 2022-03-03 | Ridley Irina General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +83,530 | 83,530 |
Page 15 of 19 · 362 trades